about
us
At Entheos Labs, we are committed to transforming the future of mental health and making improvements to the quality of our conscious experience.
​
Through our research we hope to expand our understanding of consciousness. We believe psychedelic materials hold a key to unlocking large parts of this understanding.
Changing the future of mental health treatment through advancing the neuroscience of psychedelic medicines.
Entheos Labs is dedicated to discovering, developing, and deploying groundbreaking psychedelic-medicines to address unmet medical needs. We are focused on developing innovative treatments that are designed to help those who suffer from mood, anxiety, trauma-based, and substance use disorders.
Founding Team
Tristan Edwards
Chief Executive Officer
Jerry Rosenbaum
Chief Medical Advisor
Steve Haggarty
Chief Science Advisor
Surya Reis
Strategy & Neuroscience Advisor
Jacob Hooker
Director, Translational Biomarkers
Management Team
Tristan Edwards
Chief Executive Officer
Brian Malone
Chief Financial Officer
Les Fagen
Outside General Counsel
Darrick Balu
Chief Scientific Officer
Frances Toneguzzo
IP Portfolio and Strategy
Nick Boivin
IP Portfolio and Strategy
Meryl Christopher
Business Manager and Executive Assistant